ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
5 things to watch on the ASX 200 on Friday
Broker Notes
Where to invest $8,000 on the ASX in April 2024
Broker Notes
Leading brokers name 3 ASX shares to buy today
Share Gainers
Here are the top 10 ASX 200 shares today
Broker Notes
Brokers name 3 ASX shares to buy now
Share Fallers
Why Evolution Mining, Karoon Energy, ResMed, and Sayona Mining shares are dropping today
Healthcare Shares
Why is the ResMed share price diving 5% today?
Consumer Staples & Discretionary Shares
Which ASX shares could be next on the menu for Ozempic?
Growth Shares
Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares
Healthcare Shares
3 ASX 200 healthcare stocks that could deliver big returns for investors
Share Market News
3 unexpected ASX shares owned by top-performing fund managers
Healthcare Shares
Why two brokers have named this ASX 200 stock as a best buy
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
